๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Regulatory surrogate endpoint biomarkers

โœ Scribed by Suzanne A. Fuqua

Publisher
John Wiley and Sons
Year
1993
Tongue
English
Weight
73 KB
Volume
53
Category
Article
ISSN
0730-2312

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Genetic surrogate endpoint biomarkers in
Genetic surrogate endpoint biomarkers in early breast neoplasia
โœ D. Craig Allred ๐Ÿ“‚ Article ๐Ÿ“… 1993 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 105 KB

## Genetic Surrogate Endpoint Biomarkers in Early Breast Neoplasia "Biomarkers in Early Breast Neoplasia," presented by D. Craig Allred. The biological mechanisms of breast cancer evolution are poorly understood. Furthermore, this problem has been difficult to study because potential precursor les

Genetic surrogate endpoint biomarkers in
Genetic surrogate endpoint biomarkers in early breast neoplasia
โœ Leslie Brand ๐Ÿ“‚ Article ๐Ÿ“… 1993 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 62 KB

Carolina) discussed the relationship of oncogenes and breast cancer. Specifically, he described much of the recent work with HER-2/neu, PRADI, and p53. Some of these genetic lesions appear early in the breast cancer process and are stable as the tumors become invasive and metastasize. Dr. Liu also p

Intraepithelial neoplasia, surrogate end
Intraepithelial neoplasia, surrogate endpoint biomarkers, and cancer chemoprevention
โœ Dr. Charles W. Boone; Gary J. Kelloff ๐Ÿ“‚ Article ๐Ÿ“… 1993 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 930 KB

Neoplasia is a progression of molecular, cellular, and tissue changes starting with a critical cell mutation and advancing by clonal evolution, involving further multiple mutations and expanding mutated clones. This process is characterized by five general stages: latency, focal growth of normal-app

Cervical cancer chemoprevention, vaccine
Cervical cancer chemoprevention, vaccines, and surrogate endpoint biomarkers
โœ Michele Follen; Frank L. Meyskens Jr.; Ronald D. Alvarez; Joan L. Walker; Maria ๐Ÿ“‚ Article ๐Ÿ“… 2003 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 883 KB

At the Second International Conference on Cervical Cancer, held April 11-14, 2002, experts in cervical cancer prevention, detection, and treatment reviewed the need for more research in chemoprevention, including prophylactic and therapeutic vaccines, immunomodulators, peptides, and surrogate endpoi